Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Science Advances
|
August 31, 2022
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumors
Panayotis Pachnis, Zheng Wu, Brandon Faubert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2023
Characterisation and outcome of RAC1 mutated melanoma
Georg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Cell
|
June 1, 2024
De novo and salvage purine synthesis pathways across tissues and tumors
Diem H Tran, Dohun Kim, Rushendhiran Kesavan, et al.
Science Advances
|
November 1, 2024
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study
Lea Jessica Albrecht, Jana Garnier, Anne Zaremba, et al.
Ebiomedicine
|
September 3, 2023
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
Jan-Malte Placke, Mona Kimmig, Klaus Griewank, et al.
Nature
|
April 7, 2022
Compartmentalized metabolism supports midgestation mammalian development
Ashley Solmonson, Brandon Faubert, Wen Gu, et al.
Nature
|
August 21, 2024
Short-term post-fast refeeding enhances intestinal stemness via polyamines
Shinya Imada, Saleh Khawaled, Heaji Shin, et al.
Nature Communications
|
June 17, 2026
Reverse engineering of BNIP3 identifies a mitochondrial protective peptide
Ulrike B Hendgen-Cotta, Anna Roth, Christine Beuck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2024
Early versus late response to PD-1-based immunotherapy in metastatic melanoma
Georg C Lodde, Fang Zhao, Rudolf Herbst, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Science Advances
|
August 31, 2022
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumors
Panayotis Pachnis, Zheng Wu, Brandon Faubert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 11, 2023
Characterisation and outcome of RAC1 mutated melanoma
Georg C Lodde, Philipp Jansen, Rudolf Herbst, et al.
Cell
|
June 1, 2024
De novo and salvage purine synthesis pathways across tissues and tumors
Diem H Tran, Dohun Kim, Rushendhiran Kesavan, et al.
Science Advances
|
November 1, 2024
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 26, 2026
Real-world data on anti-PD-1 plus lenvatinib as a treatment option in pretreated advanced melanoma patients - a retrospective DeCOG study
Lea Jessica Albrecht, Jana Garnier, Anne Zaremba, et al.
Ebiomedicine
|
September 3, 2023
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
Jan-Malte Placke, Mona Kimmig, Klaus Griewank, et al.
Nature
|
April 7, 2022
Compartmentalized metabolism supports midgestation mammalian development
Ashley Solmonson, Brandon Faubert, Wen Gu, et al.
Nature
|
August 21, 2024
Short-term post-fast refeeding enhances intestinal stemness via polyamines
Shinya Imada, Saleh Khawaled, Heaji Shin, et al.
Nature Communications
|
June 17, 2026
Reverse engineering of BNIP3 identifies a mitochondrial protective peptide
Ulrike B Hendgen-Cotta, Anna Roth, Christine Beuck, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2024
Early versus late response to PD-1-based immunotherapy in metastatic melanoma
Georg C Lodde, Fang Zhao, Rudolf Herbst, et al.
Page
of 10